| Literature DB >> 24050523 |
David Price1, Peter Dale, Emma Elder, Kenneth R Chapman.
Abstract
OBJECTIVE: To identify the types, frequency and impact of asthma triggers and the relationship to asthma control among adults with asthma in Europe.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24050523 PMCID: PMC3934435 DOI: 10.3109/02770903.2013.846369
Source DB: PubMed Journal: J Asthma ISSN: 0277-0903 Impact factor: 2.515
Demographics and disease characteristics.
| Characteristic | Proportion of participants, % ( |
|---|---|
| Gender | |
| Male | 49 |
| Female | 51 |
| Age range | |
| 18–30 years | 35 |
| 31–44 years | 37 |
| 45–55 years | 27 |
| Place of residence | |
| Large town or city | 53 |
| Small town or suburbs | 31 |
| Village/hamlet | 16 |
| Working status | |
| Employed full time | 55 |
| Not currently working | 25 |
| Employed part-time | 10 |
| Self-employed | 10 |
| Do not currently smoke | 72 |
| Age at diagnosis | |
| ≤25 years of age | 68 |
| 26–40 years | 24 |
| >40 years of age | 8 |
| Duration with asthma | |
| ≤5 years | 25 |
| 6–20 years | 45 |
| >20 years | 31 |
| Asthma control: self-reported | |
| Daytime symptoms in the last 7 d | 85 |
| Night-time symptoms in the last 7 d | 79 |
| Experienced a worsening of symptoms at least once a week | 53 |
| Uncontrolled asthma (ACT score <20 points) | 76 |
| Partly controlled or uncontrolled asthma (GINA guidelines)a | 92 |
aProxy measure for GINA definition: daytime symptoms experienced more than twice a week, night-time symptoms, had to limit activities in the last four weeks, had to use rescue medication more than once a week.
Self-reported asthma triggers as ranked by the proportion of participants who have ever experienced the trigger and by how frequently the trigger was reported.
| Trigger | % who have ever experienced | Trigger | Frequency (weeks/year) |
|---|---|---|---|
| Dust or dusting | 72 | Dust or dusting | 18.6 |
| Cold, flu, infections, sinusitis | 69 | Smoking (e.g. cigarettes or cigars) | 14.2 |
| Coughing | 68 | Coughing | 11.3 |
| Smoking (e.g. cigarettes or cigars) | 60 | Exercise | 11.1 |
| Smoke | 59 | Vacuum cleaning | 10.1 |
| Smog, air pollution | 58 | Perfumes, hairspray or air fresheners | 10.0 |
| Exercise | 54 | Animals | 9.6 |
| Strong odours | 54 | Smog, air pollution | 9.5 |
| Weather changes | 51 | Smoke | 9.0 |
| Mould and mould spores | 51 | Emotions | 8.2 |
| Animals | 50 | Cleaning products | 8.2 |
| Damp places | 48 | Damp places | 8.1 |
| Humidity | 48 | Weather changes | 8.0 |
| Perfumes, hairspray or air fresheners | 48 | Humidity | 7.9 |
| Grass, mowing the lawn, weeds | 47 | Strong odours | 7.6 |
| Cold air | 45 | Mould and mould spores | 7.4 |
| Emotions | 43 | Cold air | 7.2 |
| Cleaning products | 42 | Grass, mowing the lawn, weeds | 6.9 |
| Vacuum cleaning | 41 | Lying flat | 6.8 |
| Feathers | 40 | Cold, flu, infections, sinusitis | 6.7 |
| Air conditioning | 37 | Air conditioning | 5.8 |
| Lying flat | 29 | Feathers | 5.4 |
| Your work environment | 25 | Your work environment | 4.8 |
| Rain | 19 | Rain | 3.4 |
| Food, drinks or food colourings | 19 | Food, drinks or food colourings | 3.1 |
| Alcohol | 18 | Indigestion or heart burn | 2.8 |
| Other medications | 18 | Alcohol | 2.4 |
| Indigestion or heart burn | 17 | Aspirin | 2.1 |
| Eating out at particular restaurants | 15 | Other medications | 2.0 |
| Aspirin | 15 | Eating out at particular restaurants | 1.8 |
| Hormonal changes | 14 | Hormonal changes | 1.8 |
| Paracetamol | 12 | Paracetamol | 1.6 |
Figure 1.Relationship between trigger burden (exposure and frequency) and asthma control as measured by the ACT score (total participants = 1202). Panel A depicts participants (n = 696 [58%]) with a low to medium asthma trigger burden (<16 self-reported known asthma triggers) and a low total frequency burden (annual frequency index <0.5). Panel B depicts participants (n = 107 [9%]) with a low to medium asthma trigger burden (<16 self-reported known asthma triggers) and a high total frequency burden (annual frequency index ≥0.5). Panel C depicts participants (n = 278 [23%]) with a high asthma trigger burden (≥16 self-reported known asthma triggers) and a low total frequency burden (annual frequency index <0.5). Panel D depicts participants (n = 121 [10%]) with a high asthma trigger burden (≥16 self-reported known asthma triggers) and a high total frequency burden (annual frequency index ≥0.5). The shaded area on each panel depicts well controlled asthma (ACT score >20).
Figure 2.Asthma control (ACT score) and behavioural changes. This figure depicts the frequency with which participants stratified according to asthma control (ACT score) reported making behavioural changes to avoid or minimise exposure to known asthma triggers.
Burden of asthma triggers.
| Patient groups by trigger numbers | ||||||
|---|---|---|---|---|---|---|
| Total | Very few (1–5) | Low (6–10) | Medium (11–15) | High (16 +) | Kruskal–Wallis | |
| Mean number of severe attacks in lifetime | 3.2 (median 2, range 0–99) | 2.0 (median 1, range 0–15) | 2.7 (median 2, range 0–99) | 2.6 (median 2, range 0–20) | 4.6 (median 2, range 0–99) | <0.001 |
| Mean number of times hospitalised in the last year | 0.7 (median 0, range 0–25) | 0.5 (median 0, range 0–7) | 0.5 (median 0, range 0–6) | 0.8 (median 0, range 0–25) | 0.8 (median 0, range 0–20) | 0.038 |
| Mean days missed at work or study in the last year because of asthma | 7.9 (median 2, range 0–365) | 2.9 (median 1, range 0–80) | 6.1 (median 2, range 0–288) | 6.3 (median 2, range 0–265) | 12.2 (median 2, range 0–365) | <0.001 |
Covariates associated with an increase in the socioeconomic burden of asthma (Poisson regression analysis).
| Mean severe attacks in a lifetime | Hospitalisations in the previous 12 months | Number of days of work or study missed in the previous 12 months | ||||
|---|---|---|---|---|---|---|
| Variable | Estimate (confidence interval) |
| Estimate (confidence interval) |
| Estimate (confidence interval) |
|
| Trigger burden (vs very low) | ||||||
| Low | 1.38 (1.14–1.6) | <0.01 | 1.13 (0.85–1.51) | 0.40 | 2.15 (1.94–2.39) | <0.01 |
| Medium | 1.20 (1.05–1.37) | 0.01 | 1.90 (1.47–2.49) | <0.01 | 1.93 (1.74–2.14) | <0.01 |
| High | 2.07 (1.83–2.34) | <0.01 | 1.95 (1.51–2.55) | <0.01 | 3.45 (3.13–3.81) | <0.01 |
| Age (vs <30 years) | ||||||
| 31–44 years | 0.92 (0.86–1.00) | 0.04 | 0.63 (0.54–0.73) | <0.01 | 0.99 (0.94–1.04) | 0.73 |
| >45 years | 1.06 (0.98–115) | 0.17 | 0.47 (0.39–0.57) | <0.01 | 1.48 (1.40–1.56) | <0.01 |
| Dwelling (vs rural) | ||||||
| Urban | 1.03 (0.97–1.1) | 0.36 | 0.74 (0.64–0.86) | <0.01 | 0.56 (0.53–0.58) | <0.01 |
| Country (vs Germany) | ||||||
| UK | 1.24 (1.12–1.37) | <0.01 | 0.87 (0.69–1.09) | 0.22 | 1.05 (1.00–1.11) | 0.07 |
| Spain | 1.21 (1.09–1.34) | <0.01 | 1.02 (0.83–1.25) | 0.87 | 0.59 (0.55–0.63) | <0.01 |
| France | 1.22 (1.10–1.35) | <0.01 | 0.75 (0.60–0.94) | 0.01 | 0.44 (0.41–0.47) | <0.01 |
| Italy | 0.87 (0.78–0.98) | 0.02 | 0.81 (0.64–1.01) | 0.06 | 0.62 (0.59–0.66) | <0.01 |
| Gender (vs male) | ||||||
| Female | 0.83 (0.78–0.89) | <0.01 | 0.60 (0.51–0.69) | <0.01 | 1.05 (1.01–1.09) | 0.02 |
| Asthma severity (vs mild) | ||||||
| Moderate | 1.43 (1.27–1.62) | <0.01 | 2.04 (1.52–2.80) | <0.01 | 2.00 (1.83–2.19) | <0.01 |
| Severe | 2.44 (2.13–2.80) | <0.01 | 3.41 (2.47–4.79) | <0.01 | 4.09 (3.72–4.51) | <0.01 |
| Not told | 1.82 (1.55–2.15) | <0.01 | 0.87 (0.50–1.47) | 0.61 | 0.75 (0.65–0.87) | <0.01 |